United States: Drug And Device Makers Suggest Anti-Kickback Safe Harbor Clarifications To Encourage Value-Based Health Care Arrangements

In response to the annual solicitation by the Office of Inspector General ("OIG") of the U.S. Department of Health and Human Services ("HHS") for developing new, and modifying existing, safe harbors to the anti-kickback statute,1 drug and device makers, and related trade groups, have responded with proposals to provide additional clarity around value-based health care.

The letters suggest both modifications to existing safe harbors (particularly the warranty, discount, and personal services safe harbors) and development of new safe harbors geared directly toward value-based arrangements. Although in the past OIG rejected a proposed modification of the discount safe harbor that would have allowed explicitly for bundled sales of capital and disposable items at a single purchase price,2 the industry's movement toward value-based health care may suggest that these proposals will receive more sympathetic treatment.

Warranty Safe Harbor

Under the current warranty safe harbor, manufacturers and suppliers can offer a payment under a warranty to cover replacement of their own faulty product, as long as the payment does not exceed "the cost of the item itself."3 In addition, manufacturers can offer "competitive replacement agreements," under which one manufacturer replaces another manufacturer's defective item that was covered by a warranty. Both the buyer and seller must meet certain disclosure obligations.

In its letter, the Advanced Medical Technology Association ("AdvaMed") proposes changes that (i) expressly would allow product sellers to warrant that their product will produce a clinical outcome, and (ii) would expand the expenses that may be reimbursed beyond just the cost of the product itself. AdvaMed's letter suggests that greater clarity may be needed for an arrangement where a medical device company offers a bundle of items and services to a hospital for a fixed price to achieve a specific clinical outcome, and provides a warranty for that outcome by paying a rebate if the outcome is not achieved.

AdvaMed's letter proposes a new "value-based warranties" safe harbor to provide greater clarity to new arrangements. The proposed safe harbor would incorporate many of the same disclosure obligations as the existing warranty safe harbor, but would make explicit that the arrangements covered under the safe harbor include not just items, but "value-based services." In the alternative, AdvaMed proposes removing the limitation under the existing warranty safe harbor that the warranty may only pay for the cost of the item itself, to allow, for example, payment for follow-up care or clinical outcomes related to the original item.

Discount Safe Harbor

The current discount safe harbor4 protects discounts, defined as reductions in the amount a buyer is charged based on an arms'-length transaction. Certain items explicitly are not discounts, including cash payments, supplying one good without charge to induce purchase of another (except under certain circumstances), and services provided in accordance with a personal or management services contract. The safe harbor contains a number of disclosure requirements for different types of entities that might be involved in a discount arrangement.

Both the AdvaMed letter and a letter from the Pharmaceutical Research and Manufacturers of America ("PhRMA") propose a new safe harbor based on the discount safe harbor that expressly would allow for (i) price adjustments based on achievement of a measurable clinical or cost outcome and (ii) services to be bundled with a product.

In the alternative, AdvaMed proposes modifying the discount safe harbor to protect value-based arrangements (defined as arrangements where there is a value-based price adjustment conditioned on, or calculated based on, one or more clinical and/or cost outcomes that are associated with the reimbursable items or services being sold) explicitly. PhRMA also suggests a number of additional clarifications to the existing discount safe harbor, such as broadening the definition of buyers from the three existing defined categories of buyers to include other potential buyers, such as payors; clarifying the disclosure requirements for each potential entity in a transaction (e.g., simplifying disclosure requirements, which currently are different for each category of buyer and clarifying whether a seller is responsible for ensuring that a buyer meets the disclosure obligations); and clarifying whether it is permissible for sellers to condition rebates on buyers' performance of certain services (currently, the discount safe harbor states, without perfect clarity, that services provided in accordance with a personal or management services contract are not discounts).

Personal Services Safe Harbor

The personal services safe harbor5 currently protects personal or management services provided under certain terms, including a written agreement, duration of not less than one year, fair market compensation, and aggregate compensation set in advance.

AdvaMed's letter points out the difficulty that the concept of "fair market value" creates for value-based arrangements, where a significant part of the value may be the outcome. The letter notes that the personal services safe harbor is ill-equipped to address services provided under a risk-based compensation model, where the compensation is tied to outcome and therefore the amount to be paid is not set in advance. Similarly, PhRMA notes that services may change as the buyer's needs change during the arrangement. Both suggest revising the personal services safe harbor to address these issues.

Value-Based Payment Safe Harbor

Taking a more conceptual approach, a letter from a leading medical device company notes that innovative value transfer arrangements differ substantially from arrangements contemplated under existing safe harbors, because the value being exchanged by the parties may not be monetary. Instead, the value may be in kind, such as care coordination, data analytics, and other technology solutions, which do not fit neatly under traditional applications of the existing safe harbors. For example, it may be difficult to determine fair market value for newly established cost efficiency or patient outcomes goals, as well as who derives the benefit from the arrangement. The company proposed that a new safe harbor designed around innovative value transfer arrangements would better enable companies to partner with providers to create value-based healthcare programs. In developing this new safe harbor, the company suggests guiding principles of shared financial risk, transparency, and protection of clinician/patient choice.

Other Proposals

Managed Care. PhRMA suggests clarifying the circumstances under which a drug manufacturer that has a rebate agreement with a health plan or pharmacy benefit manager ("PBM") qualifies for protection under one of the managed care safe harbors.6 For example, in the safe harbor for price reductions by contractors assuming "substantial financial risk" under managed care arrangements, PhRMA proposes additional text that payments based on clinical, cost, or utilization outcomes could be a payment methodology that puts a contractor at "substantial financial risk," reasoning that this would encourage the types of risk-sharing arrangements designed to be protected under this safe harbor.

PBMs. A pharmaceutical company's letter underscores the increasingly large role PBMs play in the healthcare system, and how they contribute to the efficient negotiation and administration of relationships between pharmaceutical manufacturers and health plans. The manufacturer proposes a new PBM safe harbor to ensure clarity in the relationship between pharmaceutical manufacturers and PBMs, particularly around PBM administrative fees. The new safe harbor would ensure that administrative fees are structured so that they do not improperly incentivize PBMs to refer certain items (through formulary inclusion or other controls) or reward higher priced drugs. Suggested principles include transparency; fair market value fees; fixed administrative fees, not percent of list price; separate negotiation of administrative fees and formulary decision-making; and separation from other PBM business lines. In the alternative, the manufacturer suggests modifying the group purchasing organization safe harbor to reference PBMs.

Adherence; Data Analytics. A pharmaceutical manufacturer also proposes new safe harbors to protect programs encouraging patient adherence to medication, and providing data and data analytics solutions.

Together, these letters demonstrate significant interest by the drug and device maker community in partnering with providers to support the shift from volume to value-based health care delivery, and underscore the important role that OIG can play in clarifying the landscape and promoting these arrangements. Industry will be watching closely to see whether OIG chooses to act on any of these proposals.


1. 42 U.S.C. § 1320a-7b; 81 Fed. Reg. 95551 (December 28, 2016).

2. OIG Semiannual Report, App. G (April 1, 2004–September 30, 2004).

3. 42 C.F.R. § 100.952(g).

4. 42 C.F.R. § 100.952(h).

5. 42 C.F.R. § 100.952(d).

6. 42 C.F.R. § 100.952(m), (t), (u).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.